Director, Scientific Publications & Information (Plainsboro)

About the DepartmentThe Clinical, Medical and Regulatory (CMR) department at Novo Nordisk is one of the most diverse and collaborative groups within the organization. From healthcare provider interactions and developing and implementing regulatory strategies with the FDA to providing medical education and collecting data to support efficacy and new product development, CMR is involved. The one thing that keeps us all marching to the same beat is our patient centered focus. At Novo Nordisk, you will help patients around the world. As their needs evolve, so does our challenge to find better and more innovative ways to improve their quality of life. We’re changing lives for a living. Are you ready to make a difference?The PositionThe Director, Scientific Publications & Information serves as the US strategic owner for integrated scientific publications, scientific information/knowledge services, and evidence dissemination excellence across therapeutic areas and lifecycle. The role leads a team of publication and information professionals; sets multi-year strategy; aligns US and global Medical Affairs, evidence generation, and launch/lifecycle priorities; and ensures compliant, timely, high-quality dissemination of company-sponsored and externally authored scientific data. Beyond content creation, the Director builds strategic information capabilities, advances responsible AI/digital solutions, manages vendors and budgets, and provides executive-ready insights that support Medical Affairs decision-making.RelationshipsReports to the Head of Scientific Communications and directly leads the Scientific Publications & Information (SP&I) team, including potential Global Business Services/shared-service resources. Partners with USO, IO and Global Medical Affairs, Clinical Development, Clinical Data Science/Evidence, Biostatistics, HEOR/RWE, Regulatory, Legal/Compliance, AI and Machine Learning, IT, Scientific Information, Clinical Reporting/Medical Writing, and affiliate/HQ publication partners.Leads, stands for (and delegates) SP&I on Core/Extended Medical Teams, Launch/Asset Planning teams, Publication Planning Groups (or IEP), Core Publications Working Groups, Global Project Teams(as needed/delegated by AVP), evidence planning forums, and governance bodies. Externally, manages compliant relationships with authors, investigators, external experts/KOLs, journal editors/publishers, congress organizers, medical writing agencies, publication/information vendors, and professional organizations/industry consortia.Essential FunctionsGeneral / Strategic Leadership and GovernanceOperates independently as the US functional leader for SP&I strategy, governance, operational excellence, and capability building across therapeutic areasOwns and refreshes integrated US publication, scientific information, and evidence dissemination strategy by therapy area/asset; ensures alignment with global plans, US medical strategy, launch/lifecycle priorities, data milestones, and stakeholder needsChairs or oversees publication planning groups, governance forums, and annual planning workshops; drives prioritization, risk management, decision documentation, and escalation of strategic or compliance issuesTranslates medical strategy, evidence gaps, landscape/competitive intelligence, stakeholder insights, and data milestones into prioritized publication and information plansDefines and reports KPIs/dashboards for plan progress, submission/publication timelines, scientific quality, journal/congress strategy, reach/engagement, author experience, compliance, budget/vendor performance, and operational efficiencyDevelops, updates, and trains stakeholders on SOPs/work practices for GPP 2022, ICMJE authorship/contributorship, disclosures, data transparency, copyright, publication systems, AI use, and audit readinessProvides executive-ready insights and recommendations to Medical Affairs leadership, Core/Extended Medical Teams, launch teams, and global partnersManages SP&I base/launch budgets, forecasting, phasing, vendor sourcing, performance management, resource allocation, and continuous improvementPublications / Scientific CommunicationsAccountable for strategy, quality, scientific rigor, and governance of manuscripts, abstracts, posters, oral presentations, plain-language summaries, publication extenders, scientific platforms, and related evidence dissemination assetsDevelops integrated journal, congress, and digital dissemination strategies aligned to launch/lifecycle milestones, data availability, scientific narrative, and external stakeholder needsEnsures clinical, RWE/HEOR, biomarker, patient-reported outcome, preclinical, health literacy/plain-language, and disease-state publications are planned and governed according to data availability and business prioritiesLeads global-local alignment and ensures US publication needs, evidence gaps, and stakeholder insights are represented in global publication plansLeads author/external expert engagement strategy and ensures compliant authorship criteria, contributorship, disclosures, acknowledgments, author agreements, and publication independenceOversees publication planning and author engagement systems, including Datavision, Envision, HCP Rex, and related dashboards, to maintain transparency, workflow discipline, metrics, and inspection readinessProvides guidance and training to internal/external stakeholders on publication strategy, scientific narrative, publication planning processes, and ethical publication practicesScientific Information / Knowledge StrategyLeads scientific information as a strategic knowledge management and decision-support capability, not only a document delivery/request fulfillment serviceOversees literature surveillance, landscape assessments, competitive intelligence, gap analyses, search reports, alerts, document delivery, subscription strategy, and copyright compliance for internal stakeholdersCreates decision-ready insights from published literature, congress data, pipeline/competitor activity, and internal evidence plans to support Medical Affairs, launch teams, evidence generation, field medical, and leadership decision-makingEstablishes governance for scientific information libraries, taxonomies, metadata, search optimization, record retention, copyright/licensing, and information-access controlsEvaluates document delivery streams, subscriptions, vendors, and literature/alerting processes to reduce redundancy, improve quality, and manage costAI, Digital, and Operational InnovationOwns the responsible AI/automation and digital roadmap for SP&I; priority use cases may include literature surveillance, gap analysis, data extraction/synthesis support, plain-language summary support, workflow automation, metrics dashboards, and knowledge managementPartners with AI/Machine Learning, IT, Legal, Compliance, Privacy, and business stakeholders to ensure human oversight, data security, copyright compliance, validation, quality control, and change managementIdentifies process improvements and technology/vendor solutions that increase speed, quality, transparency, and scalability while maintaining compliancePhysical Requirements10-20% overnight travel required.Development of PeopleEnsure that reporting personnel have individual development plans (IDP), with annual goals and measurements that are consistent with the priorities of the business, and that interim reviews are held so that their work is focused on those priorities, and they understand their level of accountability for results and the measurement process. Ensure that the IDP forms include completed learning and aspiration plans and are in place for all reporting personnel to enable the achievement of goals and capability to assume increased levels of responsibility. Manage the application and communication of all Novo Nordisk policies, procedures, and Novo Nordisk Way.QualificationsAdvanced degree in life sciences, medicine, pharmacy, public health/epidemiology, health services research, or a related biomedical discipline required; PharmD, PhD, MD/DO strongly preferred. MS/MPH acceptable with relevant experienceISMAP required. CMPP certification through ISMPP required at hire or must be obtained within 12 months of hire; active ISMPP participation expectedMinimum 10+ years of relevant experience for all candidates across academia, pharma/biotech, medical communications agency, publishing, Medical Affairs, Clinical Development, HEOR/RWE, or adjacent scientific/medical communication functionsExperience must include 7+ years in scientific publications, scientific communications, publication planning, medical communications, medical information, or adjacent biopharma evidence dissemination roles, and a minimum of 3+ years of people leadership/line-management experienceSponsor-side pharma/biotech experience strongly preferred; agency-only candidates should demonstrate strategic client leadership, publication planning ownership, budget/vendor governance, and matrix influence beyond writing/content executionDemonstrated excellence in publication strategy, scientific narrative/platform development, evidence dissemination planning, publication governance, author engagement, and impact measurement; able to critically review and improve scientific contentAdvanced understanding of drug development, launch/lifecycle planning, clinical trial design/reporting, statistics, RWE/HEOR, medical/scientific exchange, data disclosure, FDA/OPDP guardrails, OIG/PhRMA expectations, GPP 2022, ICMJE, AMA, copyright, and company SOPsProven leadership in complex global-local matrix environments, including strategy translation, portfolio prioritization, cross-functional influence, issue escalation, change management, and executive communicationPortfolio/program management expertise with ability to manage multiple assets, vendors, authors, timelines, budgets, governance requirements, and launch-sensitive deliverablesProficienc